A Phase 1 Study of the Safety and Pharmacokinetics of AGS-8M4 in Subjects With Advanced Ovarian Cancer

Clinical trial NCT00816764 · COMPLETED

Trial details

NCT number: NCT00816764
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Carcinoma Ovarian Cancer Ovarian Diseases Ovarian Neoplasms

Start date: 2008-10-01
Primary completion: 2010-06-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.